Literature DB >> 7575603

Ligand-induced conformational changes in the mineralocorticoid receptor analyzed by protease mapping.

T Trapp1, F Holsboer.   

Abstract

The human mineralocorticoid receptor (MR) binds the agonists aldosterone and cortisol and the antagonist progesterone with a comparably high affinity. We used limited proteolysis of human MR synthesized by in vitro translation to detect structural alterations induced by these different endogenous ligands. Steroid binding induces a conformational change within the receptor protein. This structural alteration renders a fragment of MR resistant to proteolysis. Agonists and antagonist vary in how well they protect the MR fragment against proteolysis. But the two agonists also differ in their ability to protect, indicating that agonists and antagonists, but also different agonists, may induce distinct conformational changes. Ligand-independent removal of MR-associated heat-shock proteins induces no detectable structural change but completely prevents ligand binding of MR.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7575603     DOI: 10.1006/bbrc.1995.2464

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Aldosterone antagonists in the treatment of hypertension and target organ damage.

Authors:  S Rajagopalan; B Pitt
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

2.  Involvement of the N-terminal region of the human mineralocorticoid receptor hormone-binding domain in agonist and antagonist binding as revealed by a new monoclonal antibody.

Authors:  S Jalaguier; B Lupo; G Hugon; M E Rafestin-Oblin; G Auzou
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

3.  Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex.

Authors:  Hirochika Kitagawa; Junn Yanagisawa; Hiroaki Fuse; Satoko Ogawa; Yoshiko Yogiashi; Atsuro Okuno; Hiromichi Nagasawa; Toshihiro Nakajima; Toshio Matsumoto; Shigeaki Kato
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

4.  Central mineralocorticoid receptors and cardiovascular disease.

Authors:  Elise P Gomez Sanchez
Journal:  Neuroendocrinology       Date:  2009-07-07       Impact factor: 4.914

5.  Antagonism in the human mineralocorticoid receptor.

Authors:  J Fagart; J M Wurtz; A Souque; C Hellal-Levy; D Moras; M E Rafestin-Oblin
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

6.  Mycobacterium tuberculosis RecA intein, a LAGLIDADG homing endonuclease, displays Mn(2+) and DNA-dependent ATPase activity.

Authors:  N Guhan; K Muniyappa
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

7.  Characterization of the DNA-binding and dimerization properties of the nuclear orphan receptor germ cell nuclear factor.

Authors:  H Greschik; J M Wurtz; P Hublitz; F Köhler; D Moras; R Schüle
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

8.  Native rat kidney mineralocorticoid receptor is a phosphoprotein whose transformation to a DNA-binding form is induced by phosphatases.

Authors:  M D Galigniana
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

Review 9.  Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology.

Authors:  Alessandro Cannavo; Leonardo Bencivenga; Daniela Liccardo; Andrea Elia; Federica Marzano; Giuseppina Gambino; Maria Loreta D'Amico; Claudia Perna; Nicola Ferrara; Giuseppe Rengo; Nazareno Paolocci
Journal:  Oxid Med Cell Longev       Date:  2018-09-19       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.